161 related articles for article (PubMed ID: 35133938)
1. Seasonal Patterns of Vogt-Koyanagi-Harada Disease.
Amaral C; Rodriguez E; Barquet V; Fantauzzi A; De Jesus Rodriguez E; Ulloa-Padilla JP; Pappaterra-Rodriguez M; Requejo GA; Vila MS; Figueroa R; Fernandez CJ; Almodovar JC; Santos C; Oliver AL
Ocul Immunol Inflamm; 2023 Feb; 31(2):362-366. PubMed ID: 35133938
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, Upon Presentation, of a Cohort of Patients with Vogt-Koyanagi-Harada Disease in Puerto Rico.
Barquet V; Rodríguez E; Fantauzzi A; Ortíz JC; Ulloa-Padilla JP; Vilá-Delgado MS; Fernández CJ; Almodóvar JC; Santos C; Oliver AL
P R Health Sci J; 2021 Nov; 40(4):168-173. PubMed ID: 35077075
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada disease in pediatric, adult and elderly: clinical characteristics and visual outcomes.
Yang P; Liao W; Pu Y; Zhong Z; Wang H; Yu Q; Cai J; Wang W; Su G
Graefes Arch Clin Exp Ophthalmol; 2023 Sep; 261(9):2641-2650. PubMed ID: 37058172
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population.
Kryshtalskyj MT; Roy M
Ocul Immunol Inflamm; 2022 May; 30(4):894-900. PubMed ID: 33621146
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa.
Khairallah M; Zaouali S; Messaoud R; Chaabane S; Attia S; Ben Yahia S; Hmidi K
Int Ophthalmol; 2007; 27(2-3):125-30. PubMed ID: 17203358
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
7. Vogt-koyanagi-harada syndrome.
Fang W; Yang P
Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada Syndrome in Brazilian Children.
Marquezan MC; Nascimento H; Dalbem D; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2020 Apr; 28(3):402-408. PubMed ID: 31120768
[No Abstract] [Full Text] [Related]
9. A COVID-19 perspective of Vogt-Koyanagi-Harada disease.
Dutta Majumder P; Sadhu S; González-López JJ; Mochizuki M
Indian J Ophthalmol; 2023 Jun; 71(6):2587-2591. PubMed ID: 37322685
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 87 cases with Vogt-Koyanagi-Harada disease.
Mondkar SV; Biswas J; Ganesh SK
Jpn J Ophthalmol; 2000; 44(3):296-301. PubMed ID: 10913650
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada disease in a Native American population in Oklahoma.
Reddy AK; John FT; Justin GA; Dahr SS
Int Ophthalmol; 2021 Mar; 41(3):915-922. PubMed ID: 33403519
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.
Tugal-Tutkun I; Ozyazgan Y; Akova YA; Sullu Y; Akyol N; Soylu M; Kazokoglu H
Int Ophthalmol; 2007; 27(2-3):117-23. PubMed ID: 16957877
[TBL] [Abstract][Full Text] [Related]
13. Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease.
Yoshitomi S; Harada Y; Hiyama T; Yuasa Y; Hirooka K; Kiuchi Y
Int Ophthalmol; 2023 Aug; 43(8):2857-2866. PubMed ID: 36929369
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area.
Herbort CP; Tugal-Tutkun I; Khairallah M; Abu El Asrar AM; Pavésio CE; Soheilian M
Int Ophthalmol; 2020 Sep; 40(9):2423-2433. PubMed ID: 32418076
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
Alvarez-Guzman C; Valdez-Garcia JE; Ruiz-Lozano RE; Rodriguez-Garcia A; Navas-Villar CF; Hartleben-Matkin C; Pedroza-Seres M
Int Ophthalmol; 2022 Dec; 42(12):3913-3921. PubMed ID: 35789316
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
17. Vogt Koyanagi Harada Disease In Paediatric Age Group: Clinical Characteristics, Remission, Recurrences and Complications in Asian Indian Population.
Kaza H; Tyagi M; Agarwal K; Behera S; Pappuru RR; Mohan S; Saldanha M; Videkar C; Basu S; Pathengay A; Murthy S
Semin Ophthalmol; 2022 Feb; 37(2):187-192. PubMed ID: 34224303
[TBL] [Abstract][Full Text] [Related]
18. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
19. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.
Herbort CP; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
